In this study, the potential therapeutic effect of a monoclonal PlGF antibody and its mechanism of action in the inhibition of wound healing after glaucoma filtration surgery were evaluated and compared with the effects of an antibody to VEGF-R2. This evidence concerns the gene PGF and glaucoma.